Lung disease associated with amiodarone treatment

Area of Science:

• Cardiology
• Pulmonology
• Pharmacology

Background:

• Amiodarone hydrochloride is a widely used antiarrhythmic medication.
• Long-term use of amiodarone is associated with various toxicities, including pulmonary complications.

Observation:

• A 68-year-old woman developed severe dyspnea and weakness after 13 months of amiodarone therapy.
• Chest X-ray revealed bilateral upper lobe infiltrates.
• Symptoms and radiographic findings improved after discontinuing amiodarone and initiating steroid treatment.

Findings:

• The patient experienced amiodarone-induced pneumonitis and pulmonary fibrosis.
• Complete resolution of radiographic abnormalities was not achieved, with residual fibrosis noted.
• Treatment involved amiodarone discontinuation and corticosteroid therapy.

Implications:

• This case highlights the importance of monitoring for pulmonary toxicity during long-term amiodarone use.
• Early recognition and intervention, including drug cessation and appropriate treatment, are crucial for managing amiodarone-induced lung injury.
• Pulmonary fibrosis may persist even after treatment, underscoring the potential for long-term sequelae.